Newsweek8h
FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
They are barred from using medical jargon, distracting visuals or audio effects. Exterior view of the headquarters of US Food ...
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
WOFL2h
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...
European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
Let The Numbers Speak: Prescription Drug Provisions In The Inflation Reduction Act
The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...
Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows
By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...
How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how
UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...
Ozempic: 8 common side effects of the weight-loss drug
Ozempic (semaglutide) is a well-known prescription drug that’s used to treat blood sugar of people with type 2 diabetes, has ...
wbng27m
New York State Clean Slate Act to go into effect
ALBANY (WBNG) -- New York State’s Clean Slate Act officially goes into effect on Nov. 16. The law will seal certain criminal ...
Supreme Court rejects PIL for mandatory disclosure of drug side effects by doctors
The Supreme Court rejected a plea requiring doctors to list all drug side effects for patients in their regional language.
Kronos Bio explores significant cost cuts after pulling out of sole clinical trial drug
Kronos Bio has given up on its only drug in clinical trials after some patients suffered neurological problems like ...